Skip to main content
Equibles

GAMMA Investing LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 2010235 FOSTER CITY, CA
Back to ROIV Full portfolio

Position in ROIV

as of Sep 30, 2026 · filed Oct 8, 2026
Position Value
$650,616
+$132,613 QoQ
Shares Held
17,791
+21.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#5
of 20 holders
Holding Since
Dec 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ROIV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Sep 30, 2026

GAMMA Investing LLC holds $25,084,515 across 307 Biotechnology names. ROIV ranks #7 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 7,569 $3,957,148
2 MRNA
Moderna, Inc.
 16,136 $3,107,309
3 REGN
Regeneron Pharmaceuticals, Inc.
 2,306 $1,748,570
4 INCY
Incyte Corp
 8,598 $1,043,367
5 TECH
BIO-TECHNE Corp
 12,226 $886,018
6 EXEL
Exelixis, Inc.
 12,227 $714,179
7 ROIV
Roivant Sciences Ltd.
This page 		17,791 $650,616
8 CORT
Corcept Therapeutics Inc
 5,609 $646,325

All Filings in ROIV

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-09-30 $650,616 17,791
2026-06-30 $518,003 14,637
2026-03-31 $345,280 12,465
2025-12-31 $239,546 11,039
2025-09-30 $140,739 9,302
2025-06-30 $89,912 7,978
2025-03-31 $65,514 6,493
2024-12-31 $41,972 3,548
2024-09-30 $26,080 2,260
2024-06-30 $22,123 2,093
2024-03-31 $13,248 1,257
2023-12-31 $12,813 1,141